Asymmetry Capital Management as of Dec. 31, 2018
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 23 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed (INSM) | 13.5 | $4.9M | 373k | 13.12 | |
| Global Blood Therapeutics In | 12.1 | $4.4M | 107k | 41.05 | |
| Ptc Therapeutics I (PTCT) | 10.5 | $3.8M | 111k | 34.32 | |
| Portola Pharmaceuticals | 9.2 | $3.3M | 170k | 19.52 | |
| Aerie Pharmaceuticals | 5.7 | $2.1M | 58k | 36.10 | |
| Incyte Corporation (INCY) | 5.5 | $2.0M | 32k | 63.60 | |
| Centene Corporation (CNC) | 5.2 | $1.9M | 16k | 115.33 | |
| UnitedHealth (UNH) | 4.7 | $1.7M | 6.9k | 249.13 | |
| Neurocrine Biosciences (NBIX) | 4.1 | $1.5M | 21k | 71.41 | |
| CVS Caremark Corporation (CVS) | 3.9 | $1.4M | 22k | 65.50 | |
| Inogen (INGN) | 3.5 | $1.3M | 10k | 124.21 | |
| Penumbra (PEN) | 3.4 | $1.2M | 10k | 122.22 | |
| DaVita (DVA) | 3.0 | $1.1M | 21k | 51.47 | |
| Amicus Therapeutics (FOLD) | 2.6 | $932k | 97k | 9.58 | |
| Acceleron Pharma | 2.2 | $808k | 19k | 43.53 | |
| Heron Therapeutics (HRTX) | 2.2 | $801k | 31k | 25.96 | |
| Nucana Plc american depositary shares (NCNA) | 1.7 | $624k | 43k | 14.50 | |
| Viewray (VRAYQ) | 1.6 | $589k | 97k | 6.07 | |
| Verrica Pharmaceuticals (VRCA) | 1.4 | $512k | 63k | 8.14 | |
| Equillium (EQ) | 1.4 | $497k | 61k | 8.16 | |
| Bio-Rad Laboratories (BIO) | 1.1 | $405k | 1.7k | 232.09 | |
| Kadmon Hldgs | 1.1 | $401k | 193k | 2.08 | |
| DURECT Corporation | 0.3 | $112k | 229k | 0.49 |
